Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
LMST01020021 | CE(14:1) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | - | pmol/sample |
LMST01020021 | CE(14:1) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | - | pmol/sample |
LMST01020021 | CE(14:1) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | - | pmol/sample |
LMST01020021 | CE(14:1) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | - | pmol/sample |
LMST01020021 | CE(14:1) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | - | pmol/sample |
LMST01020021 | CE(14:1) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | - | pmol/sample |
LMST01020021 | CE(14:1) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | - | pmol/sample |
LMST01020021 | CE(14:1) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | - | pmol/sample |
LMST01020021 | CE(14:1) | C | 0.0 | BCD100322A01 | - | pmol/sample |
LMST01020021 | CE(14:1) | C | 0.5 | BCD100322A03 | - | pmol/sample |
LMST01020021 | CE(14:1) | C | 1.0 | BCD100322A07 | - | pmol/sample |
LMST01020021 | CE(14:1) | C | 2.0 | BCD100322A11 | - | pmol/sample |
LMST01020021 | CE(14:1) | C | 4.0 | BCD100322A15 | - | pmol/sample |
LMST01020021 | CE(14:1) | C | 8.0 | BCD100322A19 | - | pmol/sample |
LMST01020021 | CE(14:1) | C | 12.0 | BCD100322A23 | - | pmol/sample |
LMST01020021 | CE(14:1) | C | 24.0 | BCD100322A27 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 1.22 | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 1.38 | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol | 0.5 | BCD100322A04 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol | 1.0 | BCD100322A08 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol | 2.0 | BCD100322A12 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol | 4.0 | BCD100322A16 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol | 8.0 | BCD100322A20 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol | 12.0 | BCD100322A24 | - | pmol/sample |
LMST01020021 | CE(14:1) | 25OH-Chol | 24.0 | BCD100322A28 | - | pmol/sample |